Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.
Company profile
Ticker
TKPHF, TAK
Exchange
Website
CEO
Christophe Weber
Employees
Location
SEC CIK
Latest filings (excl ownership)
Latest ownership filings
No filings
Institutional ownership, Q3 2023
5.1% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 303 |
Opened positions | 39 |
Closed positions | 37 |
Increased positions | 108 |
Reduced positions | 92 |
13F shares | Current |
---|---|
Total value | 1.23 tn |
Total shares | 80.16 mm |
Total puts | 247.30 k |
Total calls | 1.37 mm |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
Capital Research Global Investors | 13.79 mm | $213.40 bn |
MS Morgan Stanley | 5.23 mm | $80.96 bn |
GS Goldman Sachs | 4.85 mm | $75.03 bn |
Mondrian Investment Partners | 4.08 mm | $61.23 bn |
Millennium Management | 3.76 mm | $58.20 bn |
MCQEF Macquarie | 3.76 mm | $58.16 bn |
Renaissance Technologies | 3.23 mm | $49.92 bn |
FMR | 2.59 mm | $40.12 bn |
Arrowstreet Capital, Limited Partnership | 2.47 mm | $38.22 bn |
BLK Blackrock | 2.29 mm | $35.50 bn |